We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$28.3B
AUM Growth
+$2.33B
Cap. Flow
+$1.79B
Cap. Flow %
6.32%
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$275M
2
INTU icon
Intuit
INTU
+$214M
3
CRWD icon
CrowdStrike
CRWD
+$204M
4
WSM icon
Williams-Sonoma
WSM
+$164M
5
ODFL icon
Old Dominion Freight Line
ODFL
+$150M

Sector Composition

Rank Sector Weight
1 Technology 30.61%
2 Financials 14.28%
3 Consumer Discretionary 13.77%
4 Industrials 12.88%
5 Healthcare 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAW icon
701
CS Disco
LAW
$270M
$1.09M ﹤0.01%
219,221
-84,313
-28% -$490K
LE icon
702
Lands' End
LE
$389M
$1.09M ﹤0.01%
83,078
-1,332
-2% -$20.9K
ONL
703
Orion Office REIT
ONL
$148M
$1.09M ﹤0.01%
293,489
+7,605
+3% +$29.9K
TILE icon
704
Interface
TILE
$2B
$1.08M ﹤0.01%
44,206
-155,221
-78% -$3.57M
SPRY icon
705
ARS Pharmaceuticals
SPRY
$563M
$1.07M ﹤0.01%
101,397
-551,651
-84% -$7.73M
TDUP icon
706
ThredUp
TDUP
$760M
$1.06M ﹤0.01%
761,669
-71,442
-9% -$80.1K
FHTX icon
707
Foghorn Therapeutics
FHTX
$301M
$1.06M ﹤0.01%
223,780
+94,449
+73% +$688K
VTYX
708
DELISTED
Ventyx Biosciences
VTYX
$1.05M ﹤0.01%
479,212
-89,267
-16% -$202K
CMT icon
709
Core Molding Technologies
CMT
$207M
$1.05M ﹤0.01%
63,290
-671
-1% -$11K
OMER icon
710
Omeros
OMER
$816M
$1.03M ﹤0.01%
+104,538
New +$717K
RBB icon
711
RBB Bancorp
RBB
$451M
$1.03M ﹤0.01%
50,261
-352
-0.7% -$8.13K
ALNT icon
712
Allient
ALNT
$1.42B
$1.02M ﹤0.01%
41,895
-1,853
-4% -$40.9K
ORGN
713
DELISTED
Origin Materials
ORGN
$1.01M ﹤0.01%
26,407
-51,955
-66% -$1.97M
WSR
714
DELISTED
Whitestone REIT
WSR
$995K ﹤0.01%
70,211
+1,597
+2% +$22.8K
NATR icon
715
Nature's Sunshine
NATR
$365M
$986K ﹤0.01%
67,255
-3
-0% -$44
FHN icon
716
First Horizon
FHN
$12.3B
$978K ﹤0.01%
48,571
-201,951
-81% -$3.8M
VRT icon
717
Vertiv
VRT
$104B
$978K ﹤0.01%
8,604
-17,692
-67% -$2.1M
APPF icon
718
AppFolio
APPF
$6.31B
$976K ﹤0.01%
3,956
-309
-7% -$72.3K
OSK icon
719
Oshkosh
OSK
$9.51B
$970K ﹤0.01%
10,200
-3,658
-26% -$383K
WNC icon
720
Wabash National
WNC
$541M
$963K ﹤0.01%
+56,194
New +$1.04M
HELE icon
721
Helen of Troy
HELE
$672M
$954K ﹤0.01%
15,953
-1,221
-7% -$81.2K
CDLX icon
722
Cardlytics
CDLX
$22.3M
$943K ﹤0.01%
25,405
-6,359
-20% -$243K
PYXS icon
723
Pyxis Oncology
PYXS
$184M
$939K ﹤0.01%
601,940
+219,100
+57% +$632K
AMSF icon
724
AMERISAFE
AMSF
$573M
$925K ﹤0.01%
17,939
-1,069
-6% -$57.9K
DHT icon
725
DHT Holdings
DHT
$2.99B
$919K ﹤0.01%
98,946
-58,764
-37% -$604K

Similar funds

Jacobs Levy Equity Management's Q4 2024 Portfolio in Review

As of Q4 2024, Jacobs Levy Equity Management held 1,069 positions worth $28.3B, up 9% from $25.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jacobs Levy Equity Management deployed $1.79B of net new capital in Q4 2024, opening 128 new positions and adding to 377 existing holdings. Its largest new stake was Tractor Supply: 2,947,687 shares worth $156M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Amphenol, an estimated $275M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2024 buy was Tractor Supply: 2,947,687 shares worth $156M.
  • Jacobs Levy Equity Management added most to Arista Networks in Q4 2024, an estimated $356M increase.
  • Jacobs Levy Equity Management's biggest Q4 2024 reduction was Amphenol, cutting an estimated $275M.
  • Jacobs Levy Equity Management fully exited Sarepta Therapeutics in Q4 2024, selling an estimated $94.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 26% of its $28.3B portfolio in Q4 2024.
  • Jacobs Levy Equity Management opened 128 new positions and closed 143 in Q4 2024.
  • Jacobs Levy Equity Management's portfolio value rose 9% quarter-over-quarter to $28.3B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.